Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Clonal Evolution × Lymphoid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Neoplasm, Residual 1

Interventions

Rituximab 25 Surveys and Questionnaires 23 Blood Specimen Collection 13 Gene Expression Profiling 12 Flow Cytometry 12 Amplified Fragment Length Polymorphism Analysis 12 Polymerase Chain Reaction 11 Observation 9 Microarray Analysis 9 Lenalidomide 9 obinutuzumab 8 Watchful Waiting 8 Interviews as Topic 8 ibrutinib 7 Therapeutics 7 Psychiatric Rehabilitation 7 Immunohistochemistry 7 Cytogenetic Analysis 7 Magnetic Resonance Spectroscopy 6 Vincristine 5 Prednisone 5 Immunologic Techniques 5 Drug Therapy 5 Data Collection 5 Cyclophosphamide 5 Biopsy 5 zanubrutinib 4 tisagenlecleucel 4 Inotuzumab Ozogamicin 4 In Situ Hybridization, Fluorescence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03521596 2025-11-18

FIL_BIOWM

Fondazione Italiana Linfomi - ETS

Waldenstrom Macroglobulinemia, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡